Literature DB >> 27469222

Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.

Asher Mullard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27469222     DOI: 10.1038/nrd.2016.158

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2016-08-19       Impact factor: 84.694

2.  Stem cells: Stemming the tide.

Authors:  Asher Mullard
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.